Company Data

IN8bio Inc.

Ticker
INAB
Current Price
$0.1482 -3.39%
Market Cap
$13.5M
Price Target
Refer to Report
Volume
49.1M
52wk Range
$0.112 - $1.74
Advanced Market Data

Overview

IN8bio Inc is a clinical-stage biotechnology company. It is focused on developing innovative therapies for the treatment of cancers, including solid tumors, by employing allogeneic, autologous and genetically modified gamma-delta T cells.

Inbox Intel from Channelchek.

Informed investors make more money. And it’s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy